A Study of Opaganib in Coronavirus Disease 2019 Pneumonia

Clinical trial NCT04414618 · COMPLETED

Trial details

NCT number: NCT04414618
Sponsor: RedHill Biopharma Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronavirus Infections

Start date: 2020-07-02
Primary completion: 2020-11-26
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.